Reporting owner · Q3 2026 · CIK 1838061

Michaelson Jennifer: insider trades.

Michaelson Jennifer reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($923K), across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
3
Companies
1
Name as filed
Michaelson Jennifer

Companies

CompanyRelationshipTransactions
Cullinan Therapeutics, Inc. (CGEM)Officer · Chief Scientific Officer6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-08Cullinan Therapeutics, Inc.S8,000$21.57158,844Form 4
2026-09-08Cullinan Therapeutics, Inc.M4,000$4.3166,844Form 4
2026-08-13Cullinan Therapeutics, Inc.M30,000$4.3192,844Form 4
2026-08-13Cullinan Therapeutics, Inc.S30,000$20.26162,844Form 4
2026-07-06Cullinan Therapeutics, Inc.S8,000$17.82162,844Form 4
2026-07-06Cullinan Therapeutics, Inc.M4,000$4.3170,844Form 4

Questions

What stock did Michaelson Jennifer buy or sell?

Michaelson Jennifer reported 6 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($923K), across 1 company.

Is Michaelson Jennifer the same person as other filers with this name?

This page covers SEC CIK 1838061 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/michaelson-jennifer-1838061.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.